Roche Diagnostics International AG
Company Overview
Management
Silke Hörnstein
Riehen
Chairperson of the board
Joint signing authority (any two to sign)
Claudia Böckstiegel
Risch
Member of the board
Joint signing authority (any two to sign)
Matthew Sause
Risch
Member of the board
Joint signing authority (any two to sign)
Thomas Schinecker
Baar
Member of the board
Joint signing authority (any two to sign)
Andreas Klopp
Baar
General manager
Joint signing authority (any two to sign)
Patricia Alioth
Reinach
Having right to sign
Joint signing authority (any two to sign)
Eva Bader-Hartl
Walchwil
Having right to sign
Joint signing authority (any two to sign)
Janet Baumbach
Neuenkirch
Having right to sign
Joint signing authority (any two to sign)
Bernd Bischof
Udligenswil
Having right to sign
Joint signing authority (any two to sign)
Marc Bächli
Basel
Having right to sign
Joint signing authority (any two to sign)
Bernard Colombo
Hünenberg
Having right to sign
Joint signing authority (any two to sign)
Juan Cortizo
Binningen
Having right to sign
Joint signing authority (any two to sign)
Sabine Dörhöfer
Luzern
Having right to sign
Joint signing authority (any two to sign)
Ralf Eisenbrandt
Ramlinsburg
Having right to sign
Joint signing authority (any two to sign)
Peter Eisenring
Aarau
Having right to sign
Joint signing authority (any two to sign)
Miriam Fend
Thalwil
Having right to sign
Joint signing authority (any two to sign)
Marcel Gmünder
Rotkreuz
Having right to sign
Joint signing authority (any two to sign)
Andreas Himberger
Zürich
Having right to sign
Joint signing authority (any two to sign)
Michael Hombach
Thalwil
Having right to sign
Joint signing authority (any two to sign)
Victor Jeger
Zürich
Having right to sign
Joint signing authority (any two to sign)
Building smart people network graph...
Fetching people and their companies
Address & Locations
Primary Address
| No. | Journal No. | Journal date | SOGC | SOGC date | Page / ID |
|---|---|---|---|---|---|
| 1 | (Transfer) | (Transfer) | |||
| 2 | 15407 | 27.08.2025 | 167 | 01.09.2025 | 1006421387 |
| 3 | 6267 | 02.04.2025 | 67 | 07.04.2025 | 1006301857 |
| 4 | 16045 | 24.09.2024 | 188 | 27.09.2024 | 1006139861 |
| 5 | 12368 | 19.07.2024 | 142 | 24.07.2024 | 1006092638 |
| 6 | 10013 | 13.06.2024 | 116 | 18.06.2024 | 1006059823 |
| 7 | 8001 | 10.05.2024 | 93 | 15.05.2024 | 1006032407 |
| 8 | 6526 | 15.04.2024 | 75 | 18.04.2024 | 1006012095 |
| 9 | 15357 | 26.09.2023 | 189 | 29.09.2023 | 1005848668 |
| 10 | 14401 | 07.09.2023 | 176 | 12.09.2023 | 1005836110 |
Company Purpose
Die Gesellschaft bezweckt die Forschung und Entwicklung, die Herstellung, den internationalen Handel mit und Vertrieb von Produkten aller Art, insbesondere Pharmazeutika, Diagnostika (Systeme, Reagenzien und Instrumente, digitale Lösungen etc.) und Chemikalien wie auch die Erbringung von Dienstleistungen im Zusammenhang mit diesen Produkten. Die Gesellschaft kann im In- und Ausland Grundstücke und Immaterialgüterrechte kaufen, verkaufen, nutzen und verwalten, Zweigniederlassungen, Agenturen und Verkaufsgeschäfte errichten, sich an anderen Unternehmungen beteiligen, gleichartige oder ähnliche Unternehmungen erwerben oder gründen sowie alle sonstigen Rechtshandlungen vornehmen, die geeignet sind, den Gesellschaftszweck unmittelbar oder mittelbar zu fördern.